Novigenix | Finanzwire

Basculer en Français

10184	Companies
209529	Keywords
139629	Articles
111067	Press releases

Home
Companies
Novigenix

PRESS RELEASE

published on 01/17/2024 at 08:00, 2 years 2 months ago

Revolutionizing Drug Development: Novigenix Unveils AI-Powered RNA Analysis for Immune Response Profiling
Novigenix, a leader in AI healthcare solutions, is launching LITOSeek™, a revolutionary innovation that utilizes advanced AI and RNA analysis to reshape cancer care and expedite drug development. Leveraging precision immunology, Novigenix is set to empower biopharma companies and transform cancer treatment paradigms, offering a breakthrough in personalized cancer treatment. With a team of over 20 Ph.D.-level scientists dedicated to advancing next-generation liquid biopsy solutions, Novigenix is at the forefront of pioneering precision immunology for superior patient outcomes.

Novigenix LITOSeek AI Healthcare Solutions Precision Immunology Cancer Care

Accesswire

Published on 04/09/2026 at 16:00, 54 minutes ago

Banff Half Marathon Completes 2025 Emissions Assessment, Supporting Climate Action with Karbon-X
Published on 04/09/2026 at 14:40, 2 hours 14 minutes ago

Silver X Delivers Production Growth During the First Quarter of 2026
Published on 04/09/2026 at 14:00, 2 hours 54 minutes ago

Orogen Royalties Announces Mineral Reserve and Resource Update on Producing Ermitaño Royalty
Published on 04/09/2026 at 13:30, 3 hours 24 minutes ago

Datametrex Receives $6M Purchase Order for Data Centre from Fortune 500 Conglomerate
Published on 04/09/2026 at 13:30, 3 hours 24 minutes ago

ESGold Advances Toward Production and Exploration Drilling as Mill Buildout Progresses in Parallel

View all ACCESSWIRE

EQS Group

Published on 04/09/2026 at 15:59, 54 minutes ago

Cairn Homes Plc: Holding(s) in Company
Published on 04/09/2026 at 15:57, 57 minutes ago

Cairn Homes Plc: Holding(s) in Company
Published on 04/09/2026 at 15:40, 1 hour 14 minutes ago

Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc
Published on 04/09/2026 at 15:39, 1 hour 14 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Schroders plc
Published on 04/09/2026 at 15:39, 1 hour 14 minutes ago

Form 8.3 - The Vanguard Group, Inc.: British Land Company plc, The

Les Echos

Published on 04/09/2026 at 15:57, 56 minutes ago

Filing of CNP Assurances SA 2025 universal registration document and 2025 Solvency and Financial Condition Reports
Published on 04/09/2026 at 07:00, 9 hours 54 minutes ago

bioMérieux Unveils its BIOFIRE® SPOTFIRE® Molecular Testing Solution for the Pharmaceutical Industry, Redefining Rapid Mycoplasma Testing
Published on 04/08/2026 at 18:02, 22 hours 52 minutes ago

Publication of the 2025 Universal Registration Document
Published on 04/08/2026 at 17:45, 23 hours 9 minutes ago

DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 04/08/2026 at 12:58, 1 day 3 hours ago

EURAZEO IS ASSIGNED A BBB CREDIT RATING (STABLE OUTLOOK) BY S&P AND A BBB CREDIT RATING (STABLE OUTLOOK) BY FITCH

View all LES ECHOS COMFI WIRE